Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
63 studies found for:    Alzheimer's disease | United States, Alabama
Show Display Options
Rank Status Study
1 Completed
Has Results
Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL)
Conditions: Alzheimer Disease;   Dementia
Intervention:
2 Not yet recruiting Optimizing Dementia Care Through Collaborative Recovery Interventions
Conditions: Alzheimer's Disease;   Dementia;   Dementia, Vascular;   Caregivers;   Veterans
Interventions: Behavioral: Counseling (C);   Behavioral: Care Consultation (CC)
3 Completed
Has Results
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
Conditions: Alzheimer Disease;   Dementia;   Dementia, Vascular;   Pain
Interventions: Drug: hydrocodone/APAP w placebo PRN;   Drug: hydrocodone/APAP;   Drug: placebo with hydrocodone/APAP PRN
4 Terminated
Has Results
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab;   Drug: placebo
5 Terminated
Has Results
A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients
Condition: Alzheimer Disease
Intervention: Drug: Bapineuzumab 0.5 mg/kg
6 Completed
Has Results
A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo
7 Completed Effects of ONO-2506PO in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: ONO-2506PO
8 Terminated
Has Results
An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Dimebon
9 Completed Coordinating Center for Enhancing ADRD Caregiving
Conditions: Dementia;   Alzheimer Disease
Interventions: Procedure: Skill Training Condition – problem solving training;   Procedure: REACH for TLC (Telephone Linked Computer) system
10 Completed Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
Conditions: Dementia;   Alzheimer's Disease
Intervention: Drug: Rasagiline
11 Terminated Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol
Condition: Alzheimer's Disease
Intervention: Drug: MPC-7869
12 Completed Coordinating Center for Caregiver Intervention Trial
Conditions: Dementia;   Alzheimer Disease
Interventions: Behavioral: multicomponent psychosocial intervention;   Other: Control arm
13 Completed Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
Conditions: Alzheimer Disease;   Dementia
Intervention: Drug: MPC-7869
14 Terminated A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
15 Unknown  Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Condition: Alzheimer Disease
Interventions: Drug: alphatocopherol;   Drug: Selenium;   Drug: Placebo replacement for vitamin E;   Drug: Placebo replacement for Selenium
16 Recruiting A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg/kg;   Drug: BAN2401 5.0 mg/kg;   Drug: BAN2401 10 mg/kg
17 Completed Multicenter Trial of Prednisone in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Prednisone
18 Completed Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
Condition: Alzheimer Disease
Intervention: Drug: Simvastatin
19 Completed Evaluation of Galantamine in the Treatment of Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Galantamine
20 Completed CATIE-Alzheimer's Disease Trial
Condition: Alzheimer's Disease
Interventions: Drug: Olanzapine;   Drug: Quetiapine;   Drug: Risperidone;   Drug: Citalopram

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.